Stock screener

AMLX

Conviction 80HealthcareScan · Tue, Sep 8, 2026
AMLX$33.90-0.59%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
Vol MA14 3.1M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Amylyx Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.amylyx.com ↗
Price33.90
Change-0.59%
Gap-0.87%
Rel volume0.26×
Avg volume3.67M
Avg $ vol129.86M
SMA 2032.66
SMA 5024.55
SMA 20016.97
Price vs 50+38.09%
Price vs 200+99.78%
MA stackbullish
50/200 cross—
Supertrendup · 31.42
RSI (14)62
MACD hist-0.66
MACD crossbear · 4d
Stoch %K / %D11 / 41
ADX (14)47
+DI / −DI36 / 18
RSI divergence—
MACD divergence—
ATR %+5.99%
ADR %6.33%
52w high39.66
52w low10.44
From 52w high-14.52%
Above 52w low+224.71%
New 52w highNo
SqueezeOff
Bollinger width75.23%
%B0.55
Donchian pos63.54%
Donchian high41.14
Donchian low21.28
AVWAP (52w high)36.51
vs AVWAP high-7.16%
AVWAP (52w low)18.34
vs AVWAP low+84.89%
OBV trendUp
Chaikin MF (20)0.30
Today vs 20d0.26×
Avg vol (14d)3.1M
Avg vol (20d)3.67M
Avg $ vol (20d)129.86M
Market cap3.78B
RS 3m (vs SPY)+151.58%
RS 6m (vs SPY)+131.66%
RS line new highNo
Trend template8/8
Technical rank92.8
1 week+0.44%
1 month+48.55%
3 months+160.57%
6 months+136.90%
1 year+232.35%
YTD+196.85%
P/E-26.10
P/B15.79
P/S—
P/FCF-30.59
EPS-1.53
Div yield—
ROE-60.52%
ROA-54.71%
Debt/Eq—
Current12.12
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth52.03%
Price target43.00
Target upside26.84%
Analyst ratingBuy
Institutional100.45%
Ent. value3.73B
Revenue0
Net income-43.42M
Gross profit—
Free cash flow-123.48M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out111.19M
Employees136
ListedFri, Jan 7, 2022
Free float87.41M
Float %79.6%
Short interest13.43M
Days to cover7.1d
Short volume51.5%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.39 vs −$0.36
Last surprise-8.3% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank92.8 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance38.31
Support16.76
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 11
    1 scan
  2. Breaking out now
    Jun 12
    1 scan
  3. Setting up
    Jul 8 – Jul 14
    3 scans

Congress activity

Disclosed STOCK Act trades in AMLX

All disclosures →
No recent disclosed trades by Congress in AMLX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AMLX · 7 buys · 3 sells

InsiderSideShares
Firestone Karen
Director · Common Stock · 2026-08-31
Exercise25K
Firestone Karen
Director · Common Stock · 2026-08-31
Exercise25K
Firestone Karen
Director · Stock Option (right to buy) · 2026-08-31
Exercise25K
Klee Justin B.
Co-Chief Executive Officer · Common Stock · 2026-08-18
Grant60.04K
FRATES JAMES M
Chief Financial Officer · Common Stock · 2026-08-18
Grant22.81K
Bedrosian Camille L
Chief Medical Officer · Common Stock · 2026-08-18
Grant22.81K
Cohen Joshua B
Co-Chief Executive Officer · Common Stock · 2026-08-18
Grant60.04K
Mazzariello Gina
Chief Legal Officer · Common Stock · 2026-08-18
Grant21.28K
Mazzariello Gina
Chief Legal Officer · Common Stock · 2026-07-10
Sell15K
Mazzariello Gina
Chief Legal Officer · Common Stock · 2026-07-09
Sell15K

SEC filings

EDGAR filings in AMLX · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.